Regional Reit Limited (LON:RGL) “Buy” Rating Maintained by Analysts at Peel Hunt; With GBX 125.00 Target; Last Week Magellan Health, Inc. (MGLN) Analysts

Among 5 analysts covering Magellan Health (NASDAQ:MGLN), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Magellan Health had 22 analyst reports since July 29, 2015 according to SRatingsIntel. Barclays Capital maintained the stock with “Underweight” rating in Wednesday, November 23 report. As per Friday, December 1, the company rating was maintained by Jefferies. KeyBanc Capital Markets maintained it with “Buy” rating and $105.0 target in Friday, December 1 report. Raymond James maintained the stock with “Hold” rating in Friday, December 1 report. The stock of Magellan Health, Inc. (NASDAQ:MGLN) earned “Buy” rating by Jefferies on Monday, September 26. The stock of Magellan Health, Inc. (NASDAQ:MGLN) earned “Buy” rating by Jefferies on Wednesday, June 7. The company was maintained on Friday, June 23 by Leerink Swann. Leerink Swann upgraded the shares of MGLN in report on Thursday, March 15 to “Buy” rating. KeyBanc Capital Markets maintained Magellan Health, Inc. (NASDAQ:MGLN) rating on Wednesday, September 20. KeyBanc Capital Markets has “Buy” rating and $89.0 target. Jefferies maintained the shares of MGLN in report on Friday, October 13 with “Buy” rating. See Magellan Health, Inc. (NASDAQ:MGLN) latest ratings:

15/03/2018 Broker: Leerink Swann Rating: Buy New Target: $120.0 Upgrade
01/12/2017 Broker: Jefferies Rating: Buy New Target: $110.0 Maintain
01/12/2017 Broker: Raymond James Rating: Hold Maintain
01/12/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $105.0 Maintain
13/10/2017 Broker: Jefferies Rating: Buy New Target: $94.0 Maintain

The broker have set target price per share of GBX 125.00 on Regional Reit Limited (LON:RGL) shares. This is 27.23% from the last stock close. In a research report issued to clients on Thursday, 22 March, Peel Hunt reiterated their “Buy” rating on shares of RGL.

Magellan Health, Inc. engages in the healthcare management business in the United States. The company has market cap of $2.60 billion. The companyÂ’s Healthcare segment engages in the management of behavioral healthcare services and employee assistance program services; management of other specialty areas, including diagnostic imaging and musculoskeletal management; and the integrated management of physical, behavioral, and pharmaceutical healthcare for special populations comprising individuals with serious mental illness, dual eligibles, long-term services and supports, and other populations with unique and often complex healthcare needs. It has a 23.69 P/E ratio. This segment provides its healthcare services through its comprehensive network of medical and behavioral health professionals, clinics, hospitals, and ancillary service providers.

The stock increased 1.57% or $1.65 during the last trading session, reaching $106.85. About 105,005 shares traded. Magellan Health, Inc. (NASDAQ:MGLN) has risen 5.31% since March 22, 2017 and is uptrending. It has underperformed by 11.39% the S&P500.

Investors sentiment increased to 1.45 in 2017 Q3. Its up 0.47, from 0.98 in 2017Q2. It increased, as 12 investors sold Magellan Health, Inc. shares while 76 reduced holdings. 32 funds opened positions while 54 raised stakes. 22.27 million shares or 3.44% more from 21.53 million shares in 2017Q2 were reported. Advisory Services Ntwk Ltd Liability Com has 2,242 shares for 0.02% of their portfolio. Schwab Charles Investment Management reported 157,097 shares. Hillsdale Inv Management has invested 0.21% in Magellan Health, Inc. (NASDAQ:MGLN). Deutsche Bancshares Ag stated it has 59,773 shares. Comerica Retail Bank has 44,368 shares. Strs Ohio invested in 0.01% or 13,900 shares. Millennium invested in 0.07% or 547,001 shares. Ellington Mgmt Grp Incorporated Ltd Company accumulated 2,500 shares. Hood River Capital Management Ltd Liability reported 2.78% stake. Schroder Investment Mgmt Group stated it has 6,400 shares or 0% of all its holdings. Meeder Asset Mgmt owns 0% invested in Magellan Health, Inc. (NASDAQ:MGLN) for 30 shares. Credit Suisse Ag invested in 0% or 34,486 shares. Vanguard Group owns 2.21M shares or 0.01% of their US portfolio. Envestnet Asset holds 0% or 2,272 shares in its portfolio. Ahl Ltd Liability Partnership reported 80,846 shares.

Since September 27, 2017, it had 0 buys, and 15 sales for $26.06 million activity. On Thursday, March 1 the insider SMITH BARRY M sold $1.35 million. Kamal Mostafa sold 15,428 shares worth $1.53M. WEST JEFFREY N sold $1.60M worth of stock. $2.89 million worth of Magellan Health, Inc. (NASDAQ:MGLN) shares were sold by Rubin Jonathan N. Shares for $2.27M were sold by GREGOIRE DANIEL N.

Regional REIT Limited invests in and manages commercial properties in the United Kingdom. The company has market cap of 368.72 million GBP. The companyÂ’s property portfolio comprises 123 properties. It has a 11.77 P/E ratio. It also engages in the rental of properties.